ScholarIQanswers from OpenAlex & ORCID
Daniel J. Lenihan
ResearcherPublications, citations & collaboration network
Daniel J. Lenihan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Daniel J. Lenihan have?
ScholarIQindexed works
Daniel J. Lenihan has 443 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Daniel J. Lenihan have?
ScholarIQcitation count
Daniel J. Lenihan has 25,435 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Daniel J. Lenihan?
ScholarIQh-index
Daniel J. Lenihan has an h-index of 64 in OpenAlex.
What is the i10-index of Daniel J. Lenihan?
ScholarIQi10-index
Daniel J. Lenihan has an i10-index of 173 in OpenAlex.
What is the ORCID of Daniel J. Lenihan?
ScholarIQorcid
The ORCID for Daniel J. Lenihan is on the source record.
What is the OpenAlex record for Daniel J. Lenihan?
ScholarIQopenalex
The OpenAlex for Daniel J. Lenihan is on the source record.
What are the most-cited papers on Daniel J. Lenihan?
ScholarIQmost cited works
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, Riccardo Asteggiano, Marianne Aznar, Jutta Bergler‐Klein, Giuseppe Boriani, Daniela Cardinale, Raúl Córdoba, Bernard Cosyns, David J. Cutter, Evandro de Azambuja, Rudolf A. de Boer, Susan Dent, Dimitrios Farmakis, Sofie Gevaert, Diana A. Gorog, Joerg Herrmann, Daniel J. Lenihan, Javid J. Moslehi, Brenda Moura, Sonja S Salinger, Richard Stephens, Thomas Suter, Sebastian Szmit, Juan Tamargo, Paaladinesh Thavendiranathan, Carlo G. Tocchetti, Peter van der Meer, Helena J. H. van der Pal, ESC Scientific Document Group, Patrizio Lancellotti, Franck Thuny, Magdy Abdelhamid, Victor Aboyans, Berthe M.P. Aleman, Joachim Alexandre, Ana Barac, Michael A Borger, Rubén Casado-Arroyo, Jennifer Cautela, Jolanta Čelutkienė, Maja Čikeš, Alain Cohen‐Solal, Kreena Dhiman, Stéphane Éderhy, Thor Edvardsen, Laurent Fauchier, Michael G. Fradley, Julia Grapsa, Sigrun Halvorsen, Michael Heuser, Marc Humbert, Tiny Jaarsma, Thomas Kahan, Aleksandra Konradi, Konstantinos C Koskinas, Dipak Kotecha, Bonnie Ky, Ulf Landmesser, Basil S Lewis, Aleš Linhart, Gregory Y H Lip, Maja‐Lisa Løchen, Katarzyna Małaczyńska-Rajpold, Marco Metra, Richard Mindham, Marie Moonen, Tomas G. Neilan, Jens Cosedis Nielsen, Anna-Sonia Petronio, Eva Prescott, Amina Rakisheva, Joe‐Elie Salem, Gianluigi Savarese, Marta Sitges, Jurriën M. ten Berg, Rhian M. Touyz, Agnieszka Tycińska, Matthias Wilhelm, José Luis Zamorano, Nadia Laredj, Parounak Zelveian, Peter P. Rainer, Fuad Samadov, Uladzimir Andrushchuk, Bernhard Gerber, Mirsad Selimović, Elena Kinova, Jure Samardžić, Evagoras Economides, Radek Pudil, Kirsten M Nielsen, Tarek A Kafafy, Riina Vettus, Suvi Tuohinen, Stéphane Éderhy, Zurab Pagava, Tienush Rassaf, Αlexandros Briasoulis
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Giuseppe Curigliano, Daniel J. Lenihan, Michael G. Fradley, Sarju Ganatra, Ana Barac, Anne Blaes, J. Herrmann, Charles Porter, Alexander R. Lyon, P Lancellotti, Aarti Patel, Jeanne M. DeCara, Joshua D. Mitchell, Eric Harrison, Javid J. Moslehi, Ronald Witteles, Maria Grazia Calabró, Roberto Orecchia, Evandro de Azambuja, J. L. Zamorano, Ronald J. Krone, Zaza Iakobishvili, Joseph R. Carver, Saro H. Armenian, Bonnie Ky, Daniela Cardinale, Carlo M. Cipolla, Susan Dent, Karin Jordan
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association
Biykem Bozkurt, Monica Colvin, Jennifer Cook, Leslie T. Cooper, Anita Deswal, Gregg C. Fonarow, Gary S. Francis, Daniel J. Lenihan, Eldrin F. Lewis, Dennis M. McNamara, Elfriede Pahl, Ramachandran S. Vasan, Kumudha Ramasubbu, Kismet Rasmusson, Jeffrey A. Towbin, Clyde W. Yancy
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
Alexander R. Lyon, Susan Dent, Susannah Stanway, Helena Earl, Christine Brezden‐Masley, Alain Cohen‐Solal, Carlo G. Tocchetti, Javid J. Moslehi, John D. Groarke, Jutta Bergler‐Klein, Vincent Khoo, Li Ling Tan, Markus S. Anker, Stephan von Haehling, Christoph Maack, Radek Pudil, Ana Barac, Paaladinesh Thavendiranathan, Bonnie Ky, Tomas G. Neilan, Yu. N. Belenkov, Stuart D. Rosen, Zaza Iakobishvili, Aaron L. Sverdlov, Ludhmila Abrahão Hajjar, Ariane Vieira Scarlatelli Macedo, Charlotte Manisty, Fortunato Ciardiello, Dimitrios Farmakis, Rudolf A. de Boer, Hadi Skouri, Thomas Suter, Daniela Cardinale, Ronald Witteles, Michael G. Fradley, Joerg Herrmann, Robert F. Cornell, Ashutosh Wechelaker, Michael J. Mauro, Dragana Milojković, Hugues de Lavallade, Frank Ruschitzka, Andrew J.S. Coats, Petar Seferović, Ovidiu Chioncel, Thomas Thum, Johann Bauersachs, María Sol Andrés, David J. Wright, Teresa López‐Fernández, Chris Plummer, Daniel J. Lenihan
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
Joerg Herrmann, Daniel J. Lenihan, Saro H. Armenian, Ana Barac, Anne Blaes, Daniela Cardinale, Joseph R. Carver, Susan Dent, Bonnie Ky, Alexander R. Lyon, Teresa López‐Fernández, Michael G. Fradley, Sarju Ganatra, Giuseppe Curigliano, Joshua D. Mitchell, Giorgio Minotti, Ninian N. Lang, Jennifer E. Liu, Tomas G. Neilan, Anju Nohria, Rupal O’Quinn, Iskra Pusic, Charles Porter, Kerry L. Reynolds, Kathryn J. Ruddy, Paaladinesh Thavendiranathan, Peter Valent